CGT has made a great breakthrough in the recent years, however the industry is facing challenges in developing stable and scalable manufacturing process for viral vectors. GenScript ProBio is dedicated in developing platforms to produce viral vectors, and currently it has robust viral vector manufacturing processes using both adherent culture and suspension culture. GenScript ProBio has vast experience in assisting several customers to submit IND to FDA and NMPA, and supporting manufacturing for clinical phase use.

In this webinar, you will learn:

• Challenges in process development of viral vector
• Viral vector manufacturing using adherent and suspension platforms
• GenScript ProBio track record

• Speaker: Dr. Mahmood Ali, Project Manager of Virus (R&D) Purification Process
• Date: Mar. 11^th, 2021
• Time: 10:00 AM SGT
•  
•  

×

Expand personal information

First Name*

Last Name*

Country/Region* --Please select the Country-- Arg'en'tina Andorra Afghanistan Algeria Antigua & Barbuda Anguilla Albania Arm'en'ia Angola American Samoa Austria Australia Aruba Aland Island Azerbaijan Bosnia & Herzegovina Barbados Bangladesh Belgium British Virgin Islands Burkina Bulgaria Bahrain Burundi B'en'in Bermuda Brunei Bolivia Brazil Bhutan Bouvet Island Botswana Belarus Belize Canada C'en'tral African Republic Cote d'Ivoire Cook Islands Chile Cameroon Cambodia China Hong Kong China Taiwan, China Macau China Colombia Cayman Islands Croatia Costa Rica Cuba Cape Verde Cyprus Czech Republic Chad Djibouti Democratic Republic of the Congo D'en'mark Dominica Dominican Republic Ecuador Estonia Egypt Eritrea El Salvador Ethiopia Equatorial Guinea Finland Fiji Federated States of Micronesia Faroe Islands Fr'en'ch polynesia France Fr'en'ch Guiana Gabon Great Britain Gr'en'ada Georgia Guernsey Ghana Germany Gibraltar Gre'en'land Gambia Guinea Guadeloupe Greece Guatemala Guam Guinea-Bissau Guyana Honduras Haiti Hungary Indonesia Ireland Israel India Iraq Iran Iceland Italy Jersey Jamaica Jordan Japan K'en'ya Kyrgyzstan Kiribati Kuwait Kazakhstan Laos Lebanon Liecht'en'stein Liberia Lesotho Lithuania Luxembourg Latvia Libya Morocco Monaco Moldova Madagascar Marshall islands Mali Myanmar (Burma) Mongolia Martinique Mauritania Montserrat Malta Mauritius Maldives Malawi Mexico Malaysia Mozambique Namibia New Caledonia Northern Mariana Islands Niger Nigeria Nicaragua Netherlands Norway Nepal Nauru New Zealand Oman Panama Peru Papua New Guinea Pakistan Poland Puerto Rico Portugal Palau Paraguay Qatar Réunion Romania Russian Federation Rwanda Republic of Serbia Republic of Macedonia Republic of the Congo Serbia Switzerland Saudi Arabia Seychelles Sri Lanka Sudan Swed'en' Singapore Scotland South Korea St. Lucia Slov'en'ia Spain Slovakia Sierra Leone San Marino S'en'egal Somalia Suriname Saint Barthélemy South Africa Samoa Sao Tome & Principe Syria Swaziland St. Vinc'en't & the Gr'en'adines St. Kitts & Nevis Turks & Caicos Islands Togo The Bahamas The Philippines Thailand Tajikistan Timor-Leste Turkm'en'istan Tunisia Turkey Trinidad & Tobago Tuvalu Tonga Tanzania United States of America (USA) Ukraine Uganda United Arab Emirates Uruguay Uzbekistan United States Virgin Islands Vatican City (The Holy See) V'en'ezuela Vietnam Vanuatu Wallis and Futuna Yem'en' Zambia Zimbabwe

State* Alaska Alabama Arkansas Arizona California Colorado Connecticut District of Columbia Delaware Florida Georgia Hawaii Iowa Idaho Illinois Indiana Kansas Kentucky Louisiana Massachusetts Maryland Maine Michigan Minnesota Missouri Mississippi Montana North Carolina North Dakota Nebraska New Hampshire New Jersey New Mexico Nevada New York Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Virginia Vermont Washington Wisconsin West Virginia Wyoming

State* Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Nova Scotia Northwest Territory Nunavut Territory Ontario Prince Edward Island Quebec Saskatchewan Yukon

State* Victoria Australian Capital Territory Tasmania NEW south wales Queensland South australia West Australia

Email Address*

Phone Number

Company Name*

Zip Code*

Interest* --Please Select-- Antibody & Protein Services Biologics Discovery Services Plasmid Viral Vectors

When do you need the service?* --Please Select-- Within three month Half a year to two years More than two years None

Validate Code*

* I agree to the Terms of Use and Privacy Policy

 I agree to receive the latest news, information, promotions, webinars and services, and acknowledge that I can opt out any time.